Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer [Phase 3]
Phase 3 clinical trial comparing nab-paclitaxel with solvent-based taxanes as first-line therapy for advanced ovarian cancer is currently re…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of surgery with maintenance targeted therapy for advanced ovarian cancer is currently recr…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies [Phase 2]
This clinical trial update reports on a Phase 2 study of XmAb20717 (Vudalimab) in selected advanced gynecologic and genitourinary cancers, w…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. [Phase 1, Phase 2]
Clinical trial update indicating an early-phase study of XNW27011 for multiple advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: ACT-Based Nursing Intervention for Ovarian Cancer Patients: A Pilot Study [NA]
A pilot study evaluating an ACT-based nursing intervention to reduce psychological distress in ovarian cancer patients. The trial status is …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer [Phase 1]
Phase 1 clinical trial of a microdevice for ovarian, fallopian tube, and peritoneal cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass
This clinical trial update indicates that Cleo Diagnostics Ltd is recruiting participants for a study evaluating a diagnostic test to assess…
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
A clinical trial network in Ontario (MOHCCN-O) is currently recruiting across multiple cancer indications, including breast, colorectal, pan…
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers
This clinical trial update shows recruitment for evaluating efficacy and tolerability of anticancer drug therapies in breast and gynecologic…
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host
Clinical trial update describing the use of personalized patient-derived xenograft models to test drug response in matching hosts. Recruitme…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients [Phase 3]
Phase 3 trial update evaluating durvalumab in combination with chemotherapy and bevacizumab, followed by maintenance durvalumab, bevacizumab…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study
A longitudinal study investigating dysregulation of whole-body metabolism in ovarian cancer is currently recruiting. The study is sponsored …
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation [Phase 2]
Phase 2 study evaluating Avutometinib alone versus combination with Defactinib in recurrent low-grade serous ovarian cancer, including KRAS-…
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer. [Phase 2]
Phase 2 clinical trial of B013 in combination with Paclitaxel for platinum-resistant recurrent ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology
A clinical trial evaluating salivary RNA in subjects scheduled for gynecologic pathology surgery is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors [NA]
A clinical trial update examining the genetic landscape of women with metastatic ovarian cancer before and during PARP inhibitor therapy.
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer
A clinical trial evaluating how BRCA1/2 gene variants affect treatment response and prognosis in ovarian cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Reproductive Health Outcomes in Young Patients With Ovarian Cancer After Surgical Treatment: A Retrospective Study
This clinical trial update describes a planned retrospective study evaluating reproductive health outcomes in young ovarian cancer patients …
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial update for JSKN003 in platinum-resistant, relapsed epithelial ovarian cancer; the study is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Patient Preferences for Precision Medicine: Determining Optimal Patient Quality of Life Using PARPi's [NA]
A University of Saskatchewan study is investigating patient preferences and quality of life in precision medicine for ovarian cancer using P…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors [Phase 1]
This Phase 1 clinical trial update evaluates CAR-macrophages targeting HER2-overexpressing solid tumors, sponsored by Carisma Therapeutics. …
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes. [NA]
A clinical trial update describing an investigation into the tumor spectrum of germline mutations in genes associated with hereditary breast…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors [Phase 2]
Phase 2 trial of Utidelone as monotherapy for advanced solid tumors, currently not recruiting.
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Pharmacokinetic Study of Tranexamic Acid [NA]
Clinical trial update on a pharmacokinetic study of tranexamic acid in epithelial ovarian cancer. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Comprehensive Outcomes for After Cancer Health [NA]
A clinical trial update from Pack Health indicates the study on comprehensive outcomes for after-cancer health is currently recruiting, cove…